YAKUGAKU ZASSHI
The Pharmaceutical Society of Japan, established in 1880, is one of Japan’s oldest and most distinguished academic societies. The Society currently has around 15,000 members. It publishes three monthly scientific journals. Chemical and Pharmaceutical Bulletin (Chem. Pharm. Bull.) began publication in 1953 as Pharmaceutical Bulletin. It covers chemistry fields in the pharmaceutical and health sciences. Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Yakugaku Zasshi is published mostly in Japanese, except for some articles related to clinical pharmacy and pharmaceutical education, which are published in English.
The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.

Chairman of Committee
Sumio Ohtsuki
Faculty of Life Sciences, Kumamoto University
Read more
17,989 registered articles
(updated on May 01, 2024)
Online ISSN : 1347-5231
Print ISSN : 0031-6903
ISSN-L : 0031-6903
0.3
2022 Journal Impact Factor (JIF)
JOURNAL PEER REVIEWED FREE ACCESS FULL-TEXT HTML ADVANCE PUBLICATION
Scopus Pubmed
Featured article
Volume 144 (2024) Issue 5 Pages 553-565
Syntheses and Structure–Activity Relationship Studies of Antitumor Bicyclic Hexapeptide RA-VII Analogues Read more
Editor's pick

This review outlines structure-activity relationship (SAR) studies focusing on the plant-derived antitumor bicyclic hexapeptide RA-VII. The SAR data, encompassing conformational properties, were obtained from designed and synthesized analogues that underwent modifications either at the amino acid side-chain or the peptide backbone, along with newly isolated RA-VII congeners from Rubiae Radix. These insights are anticipated to be invaluable for synthesizing analogues of other bioactive natural cyclic peptides incorporating unnatural amino acids.

View all featured articles
View all articles in current issue
Most viewed articles (March 2024)
Share this page
Browse by volume and issue
feedback
Top